Health & Medicine
Clinical research, disease, biotech and medical practice.
Integrating Self and System: The New Holistic Hybrid Health
A comprehensive, human-centric framework for well-being in the hybrid age, stressing agency, double literacy, and environmental sustainability.
Mechanochromic Skin Turns Touch Into Real-Time Color Maps Without Algorithms
A soft polymer skin embeds mechanochromic sensing in its molecular structure, transforming pressure into instant visible structural color, enabling high-resolution robotic touch with simple cameras and zero computational latency.
Half of Psychosis Patients Achieve PTSD Remission in Landmark Trial
A landmark UK trial demonstrates that integrated trauma-focused CBTp achieves 50% PTSD remission in patients with co-occurring psychosis, overturning decades of clinical exclusion and fear.
The Mediocrity Trap: How CRISPR Eugenics Could Erase Human Excellence
CRISPR-based embryo selection and germline editing promise designer babies but deliver only altered ones—whose strengths become hidden weaknesses. Even a 1942 eugenicist warned that eliminating bipolar disorder would produce a population of mediocrities, capable of pushing but not leaping.
These Cells Could Save Your Sight Before You Even Go Blind
Duke University researchers have engineered functional human retinal endothelial cells from induced pluripotent stem cells using Norrin–Frizzled4 signaling, enabling precise modeling of diabetic retinopathy and preventative regeneration of damaged ocular vasculature.
UpDoc AI Just Got FDA Clearance. Here’s What It Actually Does (And Doesn’t).
UpDoc AI earned FDA 510(k) clearance (K253281) for a patient-facing LLM that autonomously adjusts insulin doses between in-person visits, backed by an $18M seed from Mayo Clinic and Eli Lilly. The system operates within strict physician-defined parameters using a three-module architecture (provider portal, patient app, cloud app) and is cleared as an enhanced version of the d-Nav predicate device.
The Healing Power of Having Opinions: Reclaiming Judgment in the Clinical Space
Explore how Lauren Mizock Ph.D. reframes therapy as a constructive zone for patients' judgments, unlocking crucial evolutionary signals and overcoming cultural stigmas around negativity.
Beyond the Diagnosis: How New Medications and Person-Centered Care Are Transforming Dementia Support
Exploring how FDA-approved amyloid-targeting drugs and innovative care models are shifting dementia support from symptom management to preserving personhood and dignity.
Why AI Needs an FDA-Style Gatekeeper, According to Its Most Vocal Critic
Cognitive scientist Gary Marcus calls for a cabinet-level AI agency, an FDA-style approval process, and real liability as he warns that LLMs are both technically unreliable and dangerously misaligned.
Cannabis and Psychosis: Unpacking the Case for a Distinct Diagnostic Subtype
Recent clinical research suggests cannabis-associated psychosis is a distinct clinical entity rather than just a transient drug-induced event, challenging traditional diagnostic frameworks and calling for urgent, personalized treatment strategies.
The Invisible War on Our Hospitals and Power Grids
As essential services like hospitals and utilities grow increasingly digitized, they face escalating cyber risks. This article explores the warnings from cybersecurity experts about the fragile state of our critical infrastructure and how to build a more resilient foundation.
Restoring the Lipid Erucamide via Nanoparticles Activates Immune Cells to Slow Retinal Degeneration
A naturally occurring fatty acid amide, erucamide, when delivered via porous silicon nanoparticles, activates TMEM19-positive myeloid cells to stabilize the retinal neurovascular unit and slow vision loss in preclinical models.